Diabetes in late-life schizophrenia: Prevalence, factors, and association with clinical symptoms.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
01 2021
Historique:
received: 18 04 2020
revised: 25 08 2020
accepted: 26 09 2020
pubmed: 11 10 2020
medline: 15 5 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

The prevalence of diabetes mellitus has been found to be higher in patients with schizophrenia. Older patients are the fastest-growing segment of the schizophrenia population. However, few studies have explored diabetes in older patients with schizophrenia. Therefore, this study aimed to determine the prevalence and characteristics of factors associated with diabetes in Chinese patients with late-life schizophrenia (LLS), which has not been reported in previous studies. A total of 289 inpatients aged 60 or above who met the DSM-IV criteria for schizophrenia were recruited. The severity of psychopathology was assessed by the Positive and Negative Syndrome Scale (PANSS). Diabetes was diagnosed by fasting blood glucose tests, or oral glucose tolerance tests. The overall prevalence of diabetes in LLS patients was 25.3%. The prevalence of diabetes in female patients was significantly higher than that in male patients (35% vs. 21.53%). Other factors associated with diabetes included higher BMI, greater waistline (only for males), higher levels of triglyceride, and more severe positive symptoms. These results indicate that the prevalence of diabetes in LLS patients is similar to that in the age-matched general population. Female gender, excess weight and abdominal obesity, dyslipidemia, and clinical symptoms can be potential risk factors of diabetes in the LLS patient group.

Identifiants

pubmed: 33038565
pii: S0022-3956(20)30992-4
doi: 10.1016/j.jpsychires.2020.09.026
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-49

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Lijuan Huo (L)

Department of Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, 510000, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, 510000, China.

Xiaobing Lu (X)

Department of Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, 510000, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, 510000, China.

Fengchun Wu (F)

Department of Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, 510000, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, 510000, China.

Xingbing Huang (X)

Department of Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, 510000, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, 510000, China.

Yuping Ning (Y)

Department of Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, 510000, China; The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510000, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, 510000, China. Electronic address: ningjeny@126.com.

Xiang Yang Zhang (XY)

CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, 100101, China. Electronic address: zhangxy@psych.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH